A Randomized, Double-Blind, Parallel-Group Trial Evaluating Safety and Efficacy of Salmeterol 50mcg BID and Fluticasone Propionate 250mcg BID Individually and in Combination and Placebo in Subjects with Asthma

Authors
Category Primary study
Registry of TrialsGSK Study Register
Year 2005
Study Period: August 1996 ‐ July 1997. Study number SFCA3003
Epistemonikos ID: 797ba623fb55776c819677e6b62037de85dd7b40
First added on: Aug 21, 2024